A practising diabetologist's complete guide to managing and preventing the most common side effects of GLP-1 medications — written for Indian patients starting or switching treatment. Medically reviewed by Dr. Manuj Sondhi, MRCP (UK), MD, DNB — Consultant Physician & Diabetologist, Nirvana Clinic, Greater Noida · Last updated: 10 July 2026Part of the complete GLP-1 Therapy Guide for India →
In my clinic at Nirvana Clinic, Greater Noida, the most common reason patients stop their Ozempic or Mounjaro too soon is not because it isn't working — it is because nobody warned them adequately about what the first 4–6 weeks feel like. This guide is my attempt to fix that.
GLP-1 medications — including Ozempic (semaglutide), Mounjaro (tirzepatide), Rybelsus, Wegovy, and the new generic semaglutide brands launched in India from March 2026 — work by slowing stomach emptying, reducing appetite, and changing how your brain registers hunger. These same mechanisms that make them so effective for weight loss and diabetes also cause most of their side effects.
The critical reassurance: the vast majority of side effects are gastrointestinal, dose-related, temporary, and preventable with the right strategies. In clinical trials, most patients who experienced nausea reported it improving significantly after the first 4 weeks.
In the SURMOUNT-1 trial for Mounjaro, approximately 80% of patients who initially experienced nausea reported improvement by week 8 without stopping the drug. Premature discontinuation is the biggest obstacle to successful treatment.
The most commonly reported side effect. Usually peaks in the first 2–4 weeks at each dose increase, then improves significantly.
Top prevention:
More common with Mounjaro than Ozempic. Usually mild, transient, and worsened by fatty foods or skipping meals.
Top prevention:
Often from reduced calorie intake and metabolic adjustment. Typically lasts 2–3 weeks. Protein intake is the key lever.
Top fix:
More common with Ozempic/semaglutide than tirzepatide. Caused by slower gut motility — the same mechanism that reduces appetite.
Top fix:
Usually linked to eating too quickly or eating a large meal. Most patients who vomit on GLP-1s report eating faster than their new stomach pace.
Top prevention:
Pancreatitis, gallstones, kidney injury from dehydration. All are rare but require immediate medical attention. Supervised treatment prevents most of these.
Seek emergency care if:
Not all GLP-1 medications have the same side effect profile. Here is how the main drugs available in India compare, based on clinical trial data and real-world prescribing experience.
| Side Effect | Mounjaro (Tirzepatide) | Ozempic / Generic Semaglutide | Rybelsus (Oral) |
|---|---|---|---|
| Nausea | High (20–44%) | Moderate (15–20%) | Moderate (20%) |
| Diarrhoea | Higher (17–30%) | Moderate (8–12%) | Moderate (10%) |
| Constipation | Lower (6–9%) | Higher (10–24%) | Moderate (10%) |
| Vomiting | Moderate (9–13%) | Lower (5–8%) | Moderate (10%) |
| Fatigue | Moderate (8–11%) | Moderate (8–11%) | Similar |
| Pancreatitis risk | Rare (<1%) | Rare (<1%) | Rare (<1%) |
| Injection site reactions | Low (3–5%) | Low (5–7%) | N/A (oral) |
| Side effects improve by week 8? | ✅ Yes, in most patients | ✅ Yes, in most patients | ✅ Yes |
Sources: SURMOUNT-1 (tirzepatide), SUSTAIN-6 (semaglutide), PIONEER trials (oral semaglutide). Rates vary by dose and titration schedule.
GLP-1 medications arrived in India very recently — Mounjaro in March 2025, Ozempic in December 2025. But the metabolic science behind them is not new. In my 15+ years managing diabetes and insulin resistance, the hormonal mechanisms these drugs exploit are exactly what I have been treating clinically for years. In the patients I have been managing on these drugs since their Indian launch, Mounjaro tends to cause more nausea and diarrhoea early on, but these side effects resolve faster than with semaglutide. The slower 4-week dose titration schedule of Mounjaro, when followed correctly, dramatically reduces the severity. Patients who rush dose escalation suffer far more.
Nausea is the most common reason patients call me in the first month of GLP-1 treatment. Here is exactly what I tell them — and what works.
GLP-1 medications slow stomach emptying by 30–40%. If you continue eating the same meal sizes, your stomach stays full longer, causing persistent nausea. Your portions need to reduce by roughly one-third from day one, not after you feel nauseous.
Peak side effects occur 24–48 hours after injection for most patients. Injecting Friday evening means the worst nausea hits over the weekend when you can rest. Many patients who switched to evening injections report a dramatic reduction in daytime nausea at work.
Fatty foods delay gastric emptying further — eating a paratha or fried snack within 2 hours of your injection is a reliable way to trigger nausea. Eating quickly without chewing properly is the second trigger. Lying down within an hour of eating is the third.
Ginger tea, ginger water, or ginger tablets (250–500mg) taken 30 minutes before meals can meaningfully reduce nausea. Peppermint tea is a second option. I recommend these to every new patient before any anti-nausea medication.
If nausea is interfering with daily life, the right approach is holding at the current dose for an additional 4 weeks before escalating — not stopping the medication. In my practice, patients who are allowed to pause escalation almost always succeed with treatment. Stopping cold turkey wastes months of titration progress.
Ondansetron (4mg) or Domperidone (10mg) can be prescribed for severe nausea and are safe to use with GLP-1 medications. Do not take Metoclopramide (Perinorm) without checking with your doctor first — it has additional interactions with GLP-1 gut motility effects. Always consult before taking any anti-nausea drug alongside your GLP-1.
Fatigue is the most underreported side effect of GLP-1 medications in India. Patients often blame it on their diet or stress. In most cases, it has a specific, fixable cause.
1. Calorie deficit too severe: GLP-1s suppress appetite strongly. Many patients inadvertently drop to 600–800 kcal/day. Minimum safe intake is 1,000–1,200 kcal/day. 2. Protein deficiency: Fat-free mass is lost alongside fat when protein is insufficient. Ensure at least 1g/kg body weight of protein daily. 3. Micronutrient depletion: Particularly B12, iron, and magnesium — all worth checking at your 8-week blood test.
In clinical trials, approximately 11% of Wegovy patients and 8–11% of Mounjaro patients reported fatigue as a side effect. The majority resolved within 4–8 weeks as appetite regulation stabilised and calorie intake recovered to a safe level.
At Nirvana Clinic, every patient on GLP-1 therapy receives a high-protein Indian meal plan to prevent this specific problem. Common practical targets: 2 eggs or 100g paneer at breakfast, 100–150g chicken/fish or 150g dal at lunch and dinner, Greek yoghurt as a snack. These are non-negotiable while on GLP-1 therapy to preserve muscle mass.
It may seem strange that the same drug causes diarrhoea in some patients and constipation in others — but both are explained by GLP-1's effect on gut motility, which varies between individuals.
Diarrhoea is more common with Mounjaro (tirzepatide) and tends to hit in the first 2–4 weeks. It is usually triggered by fatty or high-sugar foods. The solution is temporary: reduce fat intake to under 30% of calories, avoid fried foods, and drink ORS if diarrhoea lasts more than 24 hours.
Constipation is more common with Ozempic and semaglutide brands. Slower gastric motility means slower transit throughout the gut. Increasing water intake to 2.5–3 litres daily, adding Isabgol (psyllium husk) once daily before bed, and short walks after meals are the three most effective interventions in my clinical experience.
Generic dietary advice does not work here. Indian meals are high in carbohydrates, moderate in protein, and often high in fat — which is a challenging combination for GLP-1 therapy. Here is what I advise my patients specifically.
Rather than three large traditional meals, most GLP-1 patients in India do better on a pattern of three smaller meals and two high-protein snacks (e.g. a boiled egg mid-morning, Greek yoghurt in the afternoon). This maintains protein intake without overwhelming a slower-emptying stomach.
The single most reassuring thing I can tell a new patient is this: side effects follow a predictable pattern. Knowing what comes when makes the early weeks far easier to get through.
Nausea, mild diarrhoea, and fatigue are most intense in the first fortnight. This is when most patients consider quitting — and when it's most important to hold firm. Reduce meal sizes, avoid fatty foods, inject in the evening. Most patients rate this phase 3–4/10 for discomfort.
For most patients, nausea begins improving significantly by week 3. The body adapts to the slower gastric emptying. Appetite suppression stabilises. Energy levels begin to recover as calorie intake reaches a sustainable level. Weight loss typically becomes noticeable here.
Each dose increase restarts a milder version of the initial side effects for 1–2 weeks. This is normal and expected. Patients who have already adapted tend to find each escalation easier than the last. Constipation may become more prominent in this phase — increase water and Isabgol.
By the 12-week mark, the vast majority of patients on their stable maintenance dose report that GI side effects have resolved or are minimal. Ongoing issues at this stage usually indicate either a food-related trigger or the need for a dose adjustment. A consultation review is recommended at 12 weeks regardless.
The side effects described above are expected and manageable. The following are not normal and require immediate medical attention. Do not wait for your next scheduled appointment.
Severe upper abdominal pain that radiates to the back (may indicate pancreatitis) · Complete inability to keep any fluids down for more than 24 hours (dehydration risk) · Yellowing of skin or eyes (jaundice — possible gallbladder issue) · Severe chest pain or palpitations · Signs of a severe allergic reaction: swelling of face, throat, difficulty breathing · Blood in stool or black, tarry stools
Call Dr. Manuj Sondhi: +91 8800262767 · Emergency: 112
Nausea or vomiting persists beyond 6 weeks without improvement · You have lost more than 1.5 kg per week consistently (too rapid) · Fatigue is severe and interfering with daily functioning · You have not had a bowel movement in 5+ days despite hydration measures · You are considering stopping treatment — always discuss before stopping.
For most patients, the worst nausea occurs in the first 2–4 weeks after starting or after each dose increase, then improves significantly. By week 8, the majority of patients report nausea as minimal or resolved. If nausea persists beyond 6 weeks without improvement, contact your prescribing doctor — a dose adjustment or medication review may be needed.
Clinical trial data shows Mounjaro (tirzepatide) has a slightly higher nausea rate (20–44%) than Ozempic/semaglutide (15–20%), particularly in the early weeks. However, Mounjaro's slower 4-week dose titration schedule, when followed correctly, results in side effects that are often more manageable than patients expect. In my practice, patients who follow dietary guidance report similar levels of discomfort between the two drugs.
Yes, with guidance. Ondansetron (4mg) and Domperidone (10mg) are commonly prescribed alongside GLP-1 medications for nausea and are considered safe in this combination. Avoid self-medicating with Metoclopramide without checking with your doctor. Always inform your prescribing physician before adding any anti-nausea medication.
Fatigue on semaglutide is almost always related to one of three causes: (1) eating too few calories — your appetite is suppressed but you must maintain a minimum of 1,000–1,200 kcal/day; (2) insufficient protein intake leading to early muscle mass loss; (3) micronutrient deficiency, particularly B12, iron, or magnesium. A blood test at 8 weeks will identify any deficiency. Most fatigue resolves when these are corrected without needing to stop the medication.
No. Generic semaglutide contains the identical active molecule as branded Ozempic. The side effect profile is the same because the drug is the same. What can occasionally differ is the delivery device — branded Ozempic uses an auto-injector pen, while some generics use a vial-and-syringe format. Correct injection technique with a vial can take a consultation to learn. At Nirvana Clinic, we demonstrate injection technique for all patients starting generic semaglutide.
Alcohol should be avoided or minimised on GLP-1 medications for two reasons: (1) it significantly worsens nausea, as both alcohol and GLP-1s slow gastric emptying — combining them frequently leads to severe nausea or vomiting; (2) if you are on insulin or sulfonylureas alongside your GLP-1, alcohol can cause unpredictable hypoglycaemia. An occasional small drink is unlikely to cause harm, but regular drinking during the titration phase is strongly discouraged.
Yes, restarting after a break is entirely possible. The approach depends on how long you have been off the drug. If you stopped for less than 2 weeks, you can typically resume at the same dose. If you stopped for longer, your doctor will likely restart at the lowest dose and re-titrate. Restarting after a break also gives us the opportunity to review dietary strategies and injection timing to make the second attempt more successful. Please book a consultation before restarting.
Dr. Manuj Sondhi at Nirvana Clinic, Sun Twilight Mall, Opp. Delta 1 Metro Station, Greater Noida provides structured GLP-1 weight loss programmes including baseline metabolic workup, injection training, side-effect monitoring, dose titration, and dietary support. Call or WhatsApp +91 8800262767 to book an evaluation.
Don't stop your medication without speaking to a specialist first. Most side effects are manageable with the right guidance.
Medical Disclaimer: This article is for educational purposes and does not constitute medical advice. GLP-1 medications are prescription-only drugs that must be taken under the supervision of a qualified physician. Side effects, dosing, and management strategies vary by individual. Always consult your doctor before starting, stopping, or modifying any medication. Nirvana Clinic, Shop GF-93, Sun Twilight Mall, Opp. Delta 1 Metro Station, Greater Noida UP 201308.